Similar to Australia/New Zealand, in Canada 63% of alternative HD patients also undertake NHD at home, although 27% carried out SDHD at home and no patients were undertaking NHD in-centre. In the USA, the majority of patients on alternative HD regimens (85%) received in-centre dialysis with

only a small percentage (5%) undertaking NHD at home. For the overall IQDR population, 66.3% of home NHD patients dialysed 3–4 nights per week and 33.7% dialysed 5–7 nights per week.6 This compared with those receiving NHD in-centre who were almost exclusively dialysed 3–3.5 nights per week. The average treatment session lengths for home and in-centre NHD were comparable at 420 ± 70 min in-centre and find more 426.5 ± 67.5 min at home. Although the type of dialysers for alternative HD regimens is similar to conventional HD (preferably being high-flux), the Selleckchem p38 MAPK inhibitor dialysate concentration should vary between schedules4,26 (Table 3). Initial dialysate composition for SDHD is similar to that for conventional HD (Table 3),

but there are variations in NHD as listed below. The concentration of sodium in the dialysate may be similar or slightly higher for NHD. Potassium dialysate concentrations in NHD are usually similar to conventional HD and SDHD, although often not as low with most patients dialysing against 2.0 mmol/L baths. Patients often have more freedom in their diet with reduced dietary potassium restriction. Phosphate is cleared by dialysis in a time-dependent manner, and therefore SDHD and NHD result in increased phosphate removal compared with conventional HD. For SDHD, improvements in serum phosphate levels will result if the duration of dialysis is >2 h per session, although phosphate supplementation is rarely required.27,28 Phosphate removal in NHD is about two times greater than for conventional HD; and patients are often able to discontinue phosphate binders and may have less dietary phosphate restriction.9,20 Hypophosphatemia Flavopiridol (Alvocidib) can occur with NHD schedules involving 5–7 nights per week;

and intradialytic phosphate supplementation may be required with the addition of sodium phosphate to dialysate.9 In Australia, the addition of Fleet®enema solution (C.B. Fleet Company, Inc., Virginia, USA) to the acid concentrate is recommended; and 30 mL can be added to 5 L of dialysate to increase the serum phosphate by 0.25 mmol/L. Titration of phosphate is according to pre- and/or post-dialysis levels, which should be maintained in the normal range. In alternate-night NHD, post-dialysate phosphate levels are often low but rebound quickly after a few hours of completing a dialysis session and phosphate supplementation is less often required. One of the more important minerals in dialysate requiring adjustment for alternative HD regimens is calcium.